Repligen reported $404.2M in Current Liabilities for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agilent A:US USD 1.94B 75M
Align Technology ALGN:US USD 1.93B 116.48M
Bio Techne TECH:US USD 128.39M 9.23M
Biomarin Pharmaceutical BMRN:US USD 588.88M 67.86M
Bruker BRKR:US USD 913.8M 49.2M
Catalent CTLT:US USD 1.53B 583M
Charles River Laboratories CRL:US USD 1.09B 77.39M
Danaher DHR:US USD 8.39B 387M
Dentsply International XRAY:US USD 1.17B 126M
Exact Sciences EXAS:US USD 412.75M 10.93M
Fluidigm FLDM:US USD 43.44M 2.73M
General Electric GE:US USD 56.95B 2.29B
Henry Schein HSIC:US USD 2.22B 78M
Illumina ILMN:US USD 2.77B 104M
IQVIA Holdings Inc IQV:US USD 5.58B 325M
Mettler Toledo International MTD:US USD 1.15B 17.21M
Myriad Genetics MYGN:US USD 137.2M 8.1M
Nanostring Technologies NSTG:US USD 58.86M 7.92M
Orasure Technologies OSUR:US USD 70.39M 1.3M
Pacific Biosciences Of California PACB:US USD 263.33M 181.69M
Patterson Companies PDCO:US USD 1.17B 29.88M
Peregrine Pharmaceuticals PPHM:US USD 87.32M 4.94M
Perkinelmer PKI:US USD 1.57B 80.77M
Repligen RGEN:US USD 404.2M 6.5M
Thermo Fisher Scientific TMO:US USD 17.11B 6B